| PI3K/AKT pathway and its mediators in thyroid carcinomas Z Nozhat, M Hedayati Molecular diagnosis & therapy 20 (1), 13-26, 2016 | 91 | 2016 |
| Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines Z Nozhat, S Mohammadi-Yeganeh, F Azizi, M Zarkesh, M Hedayati DARU Journal of Pharmaceutical Sciences 26, 93-103, 2018 | 41 | 2018 |
| Chemoprotective and chemosensitizing effects of apigenin on cancer therapy Z Nozhat, S Heydarzadeh, Z Memariani, A Ahmadi Cancer Cell International 21, 1-26, 2021 | 34 | 2021 |
| Different methods for cell viability and proliferation assay: essential tools in pharmaceutical studies Z Nozhat, MS Khalaji, M Hedayati, SK Kia Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 22 | 2022 |
| BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases M Zarkesh, A Zadeh-Vakili, M Akbarzadeh, Z Nozhat, SA Fanaei, ... Life sciences 223, 166-173, 2019 | 21 | 2019 |
| Cotton-based health care textile: A mini review M Shahriari-Khalaji, A Alassod, Z Nozhat Polymer Bulletin 79 (12), 10409-10432, 2022 | 17 | 2022 |
| Thyroid Cancer Epidemic: A Peril or an Alarm? Z Nozhat, M Hedayati, F Azizi International journal of endocrinology and metabolism 13 (4), 2015 | 15 | 2015 |
| Medullary thyroid carcinoma: a review on ethical considerations in treatment of children Z Nozhat, M Hedayati Journal of Pediatric Endocrinology and Metabolism 29 (6), 633-639, 2016 | 14 | 2016 |
| Can the serum level of myostatin be considered as an informative factor for cachexia prevention in patients with medullary thyroid cancer? M Hedayati, Z Nozhat, M Hannani Asian Pacific Journal of Cancer Prevention 17 (sup3), 119-123, 2016 | 13 | 2016 |
| Application of bacterial nanocellulose in cancer drug delivery: A review M Shahriari-Khalaji, M Zarkesh, Z Nozhat Current Pharmaceutical Design 27 (34), 3656-3665, 2021 | 11 | 2021 |
| A review on molecular biomarkers of thyroid carcinoma Z Nozhat, F Azizi, M Hedayati Journal of Mazandaran University of Medical Sciences 25 (125), 154-170, 2015 | 8 | 2015 |
| Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery Z Nozhat, S Heydarzadeh, M Shahriari-Khalaji, S Wang, MZ Iqbal, X Kong Biomaterials Science 11 (12), 4094-4131, 2023 | 6 | 2023 |
| Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer M Zarkesh, N Arab, SM Tavangar, Z Nozhat, SM Fanaei, M Hedayati Pathology-Research and Practice 229, 153694, 2022 | 6 | 2022 |
| CpG island status as an epigenetic alteration for NIS promoter in thyroid neoplasms; a cross-sectional study with a systematic review M Zarkesh, N Arab, R Abooshahab, S Heydarzadeh, S Sheikholeslami, ... Cancer Cell International 22 (1), 310, 2022 | 4 | 2022 |
| Physical Activity and Exercise Promote Peroxisome Proliferator-Activated Receptor Gamma Expression in Adipose Tissues of Obese Adults M Zarkesh, Z Nozhat, M Akbarzadeh, M Daneshpour, B Mahmoodi, ... Iranian Journal of Public Health 51 (11), 2619, 2022 | 3 | 2022 |
| Antineoplastic activity of an old natural antidiabetic biguanide on the human thyroid carcinoma cell line Z Nozhat, M Zarkesh, E Baldini, S Mohammadi-Yeganeh, F Azizi, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 3 | 2022 |
| Signaling pathways in medullary thyroid carcinoma: therapeutic implications Z Nozhat, M Hedayati, H Pourhassan International Journal of Endocrine Oncology 3 (4), 299-312, 2016 | 3 | 2016 |
| Metabolomics and thyroid cancers: new approaches for biomarkers discovery Z Nozhat, M Hedayati, F Azizi Iranian Journal of Endocrinology and Metabolism 19 (3), 133-143, 2017 | 1 | 2017 |
| Pesticide-Induced Alterations in Locomotor Activity, Anxiety, and Depression-like Behavior Are Mediated through Oxidative Stress-Related Autophagy: A Persistent Developmental … MM Ommati, Z Nozhat, S Sabouri, X Kong, S Retana-Márquez, A Eftekhari, ... Journal of agricultural and food chemistry 72 (19), 11205-11220, 2024 | | 2024 |
| Temozolomide loaded Fe3O4@ SiO2 nanoparticles for MR-imaging directed synergistic therapy of glioblastoma multiforme in vitro Z Nozhat, S Wang, A Mushtaq, T Deng, MZ Iqbal, X Kong Materials Today Communications 38, 108289, 2024 | | 2024 |
Mehdi Hedayati (Prof. in Biochemistry),Research Institute For Endocrine Sciences, Shahid Beheshti University of Medical Sciences在 sbmu.ac.ir 的电子邮件经过验证
